| Name | Title | Contact Details |
|---|---|---|
Preston Simons |
Chief Information Officer | Profile |
Terri McHenry |
Director of IP and LItigation | Profile |
Jason Woloz |
Chief Information Security Officer | Profile |
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
THE KRONOS GROUP is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hyphen is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tufts Health Care Institute is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bioptigen is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.